Themis Medicare Ltd 530199
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹289.55
- Day Range
- ₹280.35–293.20
- 52-Week Range
- ₹142.60–304.30
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹26.01 Bil
- Volume/Avg
- 17,509 / 20,943
Key Statistics
- Price/Earnings (Normalized)
- 53.34
- Price/Sales
- 6.62
- Dividend Yield (Trailing)
- 0.18%
- Dividend Yield (Forward)
- 0.18%
- Total Yield
- 0.17%
Company Profile
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,541
- Website
- https://www.themismedicare.com
Comparables
Valuation
|
Metric
|
530199
|
506879
|
524494
|
|---|---|---|---|
Price/Earnings (Normalized) | 53.34 | 74.77 | 57.87 |
Price/Book Value | 7.06 | 20.27 | 5.93 |
Price/Sales | 6.62 | 25.68 | 4.61 |
Price/Cash Flow | 75.46 | 68.12 | 41.59 |
Price/Earnings
530199
506879
524494
Financial Strength
|
Metric
|
530199
|
506879
|
524494
|
|---|---|---|---|
Quick Ratio | 1.22 | 2.61 | 1.17 |
Current Ratio | 1.90 | 2.94 | 2.35 |
Interest Coverage | 9.20 | 380.18 | 7.30 |
Quick Ratio
530199
506879
524494
Profitability
|
Metric
|
530199
|
506879
|
524494
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
530199
506879
524494
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Sgbpmpmwmb | Fswp | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Cxsjpmfxql | Xdckkjk | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Xqlxbkrjq | Txjly | $48.4 Bil | |||
| Viatris Inc
VTRS
| Ychwdxrr | Kfm | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ycvqtpsz | Jtwc | $13.5 Bil | |||
| Catalent Inc
CTLT
| Knlxcjqd | Bcbcqq | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Fcbjkdyh | Hdsvpxj | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Tlzqkmlrb | Plx | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Twrzmbfyl | Yns | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Zpzvygh | Jtzt | $2.3 Bil |
United States